← Leaderboards
Jessica S. Blackburn
University Of Kentucky
$6,035,887
Attributed
$6,035,887
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2014–24$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,035,887 · 4
By mechanism
R37$2,414,915 · 1
DP2$2,295,000 · 1
R00$980,048 · 1
K99$345,924 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Danzhou Yang$12,136,786
- Guangrong Zheng$6,917,707
- Ren Xu$8,252,231
- John Joseph Mc Carthy$7,212,078
- Kevin Murach$3,034,711
Others in their field
Top investigators on “Zebrafish”
- Leonard I Zon · Children'S Hospital Boston$58,820,730
- Monte Westerfield · University Of Oregon$50,217,878
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Karl Alexander Deisseroth · Stanford University$29,745,200
- William S Talbot · Stanford University$29,496,829
- Robert L Tanguay · Oregon State University$27,361,484
Research focus
ZebrafishLeukemiaCellsChemotherapySamplingTumor ProgressionMalignant NeoplasmsIn VivoRelapsePlayOncogenesAdverse EffectsPathway InteractionsMolecular TargetSmall MoleculeKnock-DownAdultIn VitroGenesInnovationChildCancer TypeDrug TargetingProtein Tyrosine Phosphatase
Grant awards (14)
The Phosphatase PRL3 as a MYC Target and Pro-Survival Oncogene in Acute Lymphoblastic Leukemia$332,488
R37 · FY2024 · CA · contact PI
The Phosphatase PRL3 as a MYC Target and Pro-Survival Oncogene in Acute Lymphoblastic Leukemia$342,988
R37 · FY2023 · CA · contact PI
The phosphatase PRL3 as a MYC target and pro-survival oncogene in Acute Lymphoblastic Leukemia$349,988
R37 · FY2022 · CA · contact PI
The phosphatase PRL3 as a MYC target and pro-survival oncogene in Acute Lymphoblastic Leukemia$349,988
R37 · FY2021 · CA · contact PI
The phosphatase PRL3 as a MYC target and pro-survival oncogene in Acute Lymphoblastic Leukemia$349,988
R37 · FY2020 · CA · contact PI
The phosphatase PRL3 as a MYC target and pro-survival oncogene in Acute Lymphoblastic Leukemia$339,487
R37 · FY2019 · CA · contact PI
The phosphatase PRL3 as a MYC target and pro-survival oncogene in Acute Lymphoblastic Leukemia$349,988
R37 · FY2018 · CA · contact PI
The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development$248,999
R00 · FY2018 · CA · contact PI
Harnessing Single Cell Technology to Define Self-Renewal in Normal and Malignant Stem Cells$2,295,000
DP2 · FY2017 · CA · contact PI
The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development$248,999
R00 · FY2017 · CA · contact PI
The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development$233,050
R00 · FY2017 · CA · contact PI
The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development$249,000
R00 · FY2016 · CA · contact PI
The role of the protein tyrosine phosphatase PRL3 in leukemia development$172,962
K99 · FY2015 · CA · contact PI
The role of the protein tyrosine phosphatase PRL3 in leukemia development$172,962
K99 · FY2014 · CA · contact PI